Login / Signup

Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.

Yi-Chun HuaDe-Zhi GaoKuan-Yu WangXiao-Sheng DingWei-Ran XuYu-Bin LiWei-Wei ShiShi-Bin SunXiao-Yan Li
Published in: Thoracic cancer (2023)
Bevacizumab significantly reduces the severity of PTBE after radiotherapy for lung cancer. However, its impact on tumor volume reduction and intracranial PFS does not reach statistical significance.
Keyphrases